[German version of the Skin Shame Scale (SSS-24) : Validation with dermatological patients and dermatologically healthy individuals].

Deutsche Version der Skin Shame Scale (SSS-24) : Validierung anhand dermatologischer Patienten und dermatologisch gesunder Personen.

Journal

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete
ISSN: 1432-1173
Titre abrégé: Hautarzt
Pays: Germany
ID NLM: 0372755

Informations de publication

Date de publication:
Feb 2020
Historique:
pubmed: 13 11 2019
medline: 11 2 2020
entrez: 13 11 2019
Statut: ppublish

Résumé

Skin shame plays an important role in the psychological distress of dermatological patients. However, it is rarely examined in research or clinical practice due to the lack of availability of a robust measure of skin shame. This study sought to adapt and validate the Skin Shame Scale (SSS-24) for use in the German-speaking population. The SSS-24 questionnaire was completed by 488 dermatologically healthy (DH) individuals (66.6% women) and 339 dermatological patients (DP; 66.7% women). Participants also completed measures of general shame (SHAME) and of psychological distress (BSI[Brief Symptom Inventory]-18). The SSS-24 showed adequate psychometric properties and a high internal consistency in both samples (DH: α = 0.91; DP: α = 0.95). DP reported more skin shame than DH (p < 0.001) but in both samples more skin shame was associated with more general shame and more psychological distress (p < 0.001). Overall, the psychometric properties of the English original version were replicated in the German version of the SSS-24. Due to the strong associations with general shame and psychological distress, skin shame should be considered an important parameter in psychodermatology. The SSS-24 enables further research into the role of shame in skin conditions and provides a useful tool for identifying patients who might benefit from psychosocial interventions.

Sections du résumé

BACKGROUND BACKGROUND
Skin shame plays an important role in the psychological distress of dermatological patients. However, it is rarely examined in research or clinical practice due to the lack of availability of a robust measure of skin shame. This study sought to adapt and validate the Skin Shame Scale (SSS-24) for use in the German-speaking population.
METHODS METHODS
The SSS-24 questionnaire was completed by 488 dermatologically healthy (DH) individuals (66.6% women) and 339 dermatological patients (DP; 66.7% women). Participants also completed measures of general shame (SHAME) and of psychological distress (BSI[Brief Symptom Inventory]-18).
RESULTS RESULTS
The SSS-24 showed adequate psychometric properties and a high internal consistency in both samples (DH: α = 0.91; DP: α = 0.95). DP reported more skin shame than DH (p < 0.001) but in both samples more skin shame was associated with more general shame and more psychological distress (p < 0.001).
CONCLUSIONS CONCLUSIONS
Overall, the psychometric properties of the English original version were replicated in the German version of the SSS-24. Due to the strong associations with general shame and psychological distress, skin shame should be considered an important parameter in psychodermatology. The SSS-24 enables further research into the role of shame in skin conditions and provides a useful tool for identifying patients who might benefit from psychosocial interventions.

Identifiants

pubmed: 31712973
doi: 10.1007/s00105-019-04501-5
pii: 10.1007/s00105-019-04501-5
doi:

Types de publication

Journal Article

Langues

ger

Sous-ensembles de citation

IM

Pagination

124-129

Références

J Am Acad Dermatol. 2003 Jan;48(1):128-30
pubmed: 12522383
Br J Clin Psychol. 2002 Mar;41(Pt 1):29-42
pubmed: 11931676
Hautarzt. 2003 Sep;54(9):852-7
pubmed: 12955263
Psychother Psychosom Med Psychol. 2011 Feb;61(2):82-6
pubmed: 21337286
Physiol Behav. 2000 Sep 15;70(5):567-71
pubmed: 11111012
Acta Derm Venereol. 2000 Jul-Aug;80(4):272-6
pubmed: 11028860
Br J Dermatol. 2000 Nov;143(5):983-91
pubmed: 11069507
Clin Psychol Rev. 2001 Jul;21(5):663-82
pubmed: 11434225
J Pers Soc Psychol. 1996 Jun;70(6):1256-69
pubmed: 8667166
J Dtsch Dermatol Ges. 2008 Jan;6(1):67-76
pubmed: 18021249
J Dtsch Dermatol Ges. 2016 Mar;14(3):233-52; quiz 253
pubmed: 26972185
Br J Dermatol. 2003 Feb;148(2):193-4
pubmed: 12588367

Auteurs

Michaela Hiebler-Ragger (M)

Universitätsklinik für Dermatologie und Venerologie, Medizinische Universität Graz, Auenbrugger Platz 8, 8036, Graz, Österreich.
Universitätsklinik für Psychiatrie und Psychotherapeutische Medizin, Medizinische Universität Graz, Graz, Österreich.
Center for Integrative Addiction Research (CIAR), Grüner Kreis, Wien, Österreich.

Human-Friedrich Unterrainer (HF)

Universitätsklinik für Psychiatrie und Psychotherapeutische Medizin, Medizinische Universität Graz, Graz, Österreich.
Center for Integrative Addiction Research (CIAR), Grüner Kreis, Wien, Österreich.

Andrew R Thompson (AR)

Department of Psychology, University of Sheffield, Sheffield, Großbritannien.

Stephen Kellett (S)

Department of Psychology, University of Sheffield, Sheffield, Großbritannien.

Elisabeth Aberer (E)

Universitätsklinik für Dermatologie und Venerologie, Medizinische Universität Graz, Auenbrugger Platz 8, 8036, Graz, Österreich. elisabeth.aberer@medunigraz.at.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH